A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa

Abstract Objectives We reported tet(S/M) in Streptococcus pneumoniae and investigated its temporal spread in relation to nationwide clinical interventions. Methods We whole-genome sequenced 12 254 pneumococcal isolates from 29 countries on an Illumina HiSeq sequencer. Serotype, multilocus ST and antibiotic resistance were inferred from genomes. An SNP tree was built using Gubbins. Temporal spread was reconstructed using a birth–death model. Results We identified tet(S/M) in 131 pneumococcal isolates and none carried other known tet genes. Tetracycline susceptibility testing results were available for 121 tet(S/M)-positive isolates and all were resistant. A majority (74%) of tet(S/M)-positive isolates were from South Africa and caused invasive diseases among young children (59% HIV positive, where HIV status was available). All but two tet(S/M)-positive isolates belonged to clonal complex (CC) 230. A global phylogeny of CC230 (n=389) revealed that tet(S/M)-positive isolates formed a sublineage predicted to exhibit resistance to penicillin, co-trimoxazole, erythromycin and tetracycline. The birth–death model detected an unrecognized outbreak of this sublineage in South Africa between 2000 and 2004 with expected secondary infections (effective reproductive number, R) of ∼2.5. R declined to ∼1.0 in 2005 and <1.0 in 2012. The declining epidemic could be related to improved access to ART in 2004 and introduction of pneumococcal conjugate vaccine (PCV) in 2009. Capsular switching from vaccine serotype 14 to non-vaccine serotype 23A was observed within the sublineage. Conclusions The prevalence of tet(S/M) in pneumococci was low and its dissemination was due to an unrecognized outbreak of CC230 in South Africa. Capsular switching in this MDR sublineage highlighted its potential to continue to cause disease in the post-PCV13 era.

[1]  Andries J. van Tonder,et al.  Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study , 2019, The Lancet. Infectious diseases.

[2]  Jukka Corander,et al.  International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact , 2019, EBioMedicine.

[3]  Andries J. van Tonder,et al.  Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland , 2018, Journal of Clinical Microbiology.

[4]  S. Kaplan,et al.  Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage , 2018, Emerging infectious diseases.

[5]  T. Stadler,et al.  Tuberculosis outbreak investigation using phylodynamic analysis , 2017, bioRxiv.

[6]  Cheryl P. Andam,et al.  Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi , 2017, Vaccine.

[7]  L. McGee,et al.  Validation of β-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences , 2017, BMC Genomics.

[8]  S. Bentley,et al.  Pre-vaccine serotype composition within a lineage signposts its serotype replacement – a carriage study over 7 years following pneumococcal conjugate vaccine use in the UK , 2017, Microbial genomics.

[9]  L. McGee,et al.  Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage, United States, 2015–2016 , 2017, Emerging infectious diseases.

[10]  Julian Parkhill,et al.  ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads , 2017, bioRxiv.

[11]  F. Granados-Chinchilla,et al.  Tetracyclines in Food and Feedingstuffs: From Regulation to Analytical Methods, Bacterial Resistance, and Environmental and Health Implications , 2017, Journal of analytical methods in chemistry.

[12]  S. Kaplan,et al.  Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States , 2016, Journal of Clinical Microbiology.

[13]  Lei Dai,et al.  Evolution and Diversity of the Antimicrobial Resistance Associated Mobilome in Streptococcus suis: A Probable Mobile Genetic Elements Reservoir for Other Streptococci , 2016, Front. Cell. Infect. Microbiol..

[14]  C. Whitney,et al.  Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in Streptococcus pneumoniae , 2016, mBio.

[15]  A. Lindstrand,et al.  Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden , 2016, European Respiratory Journal.

[16]  C. Whitney,et al.  Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  Andrew Rambaut,et al.  Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen) , 2016, Virus evolution.

[18]  C. Chiu,et al.  Evolving pneumococcal serotypes and sequence types in relation to high antibiotic stress and conditional pneumococcal immunization , 2015, Scientific Reports.

[19]  Aldert L. Zomer,et al.  The post-vaccine microevolution of invasive Streptococcus pneumoniae , 2015, Scientific Reports.

[20]  S. Madhi,et al.  Effects of vaccination on invasive pneumococcal disease in South Africa. , 2014, The New England journal of medicine.

[21]  A. Walker,et al.  Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England. , 2014, The Journal of infectious diseases.

[22]  A. von Gottberg,et al.  Population Snapshot of Streptococcus pneumoniae Causing Invasive Disease in South Africa Prior to Introduction of Pneumococcal Conjugate Vaccines , 2014, PloS one.

[23]  David R. Riley,et al.  Parallel Evolution of Streptococcus pneumoniae and Streptococcus mitis to Pathogenic and Mutualistic Lifestyles , 2014, mBio.

[24]  Dong Xie,et al.  BEAST 2: A Software Platform for Bayesian Evolutionary Analysis , 2014, PLoS Comput. Biol..

[25]  Jukka Corander,et al.  Dense genomic sampling identifies highways of pneumococcal recombination , 2014, Nature Genetics.

[26]  S. Gualberto,et al.  Daily ingestion of tetracycline residue present in pasteurized milk: a public health problem , 2014, Environmental Science and Pollution Research.

[27]  Andries J. van Tonder,et al.  Evidence of antimicrobial resistance-conferring genetic elements among pneumococci isolated prior to 1974 , 2013, BMC Genomics.

[28]  J. Parkhill,et al.  Pneumococcal Capsular Switching: A Historical Perspective , 2012, The Journal of infectious diseases.

[29]  S. Bonhoeffer,et al.  Birth–death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV) , 2012, Proceedings of the National Academy of Sciences.

[30]  G. Perozzi,et al.  Molecular characterization of a novel mosaic tet(S/M) gene encoding tetracycline resistance in foodborne strains of Streptococcus bovis , 2012, Microbiology.

[31]  Cheryl Cohen,et al.  The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis , 2011, AIDS.

[32]  M. Gottschalk,et al.  Spread of Streptococcus suis Sequence Type 7, China , 2008, Emerging infectious diseases.

[33]  P. Hsueh,et al.  Identification of tet(S) gene area in tetracycline-resistant Streptococcus dysgalactiae subsp. equisimilis clinical isolates. , 2007, The Journal of antimicrobial chemotherapy.

[34]  R. Bedi,et al.  Characterization of Tn916S, a Tn916-Like Element Containing the Tetracycline Resistance Determinant tet(S) , 2004, Journal of bacteriology.

[35]  Marilyn Roberts,et al.  Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance , 2001, Microbiology and Molecular Biology Reviews.

[36]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[37]  K. Klugman,et al.  Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae , 1996, Antimicrobial agents and chemotherapy.

[38]  J. M. Smith,et al.  The tetracycline resistance gene tet(M) exhibits mosaic structure. , 1996, Plasmid.

[39]  E. Charpentier,et al.  Characterization of a new class of tetracycline-resistance gene tet(S) in Listeria monocytogenes BM4210. , 1993, Gene.